Latest News
Century Therapeutics, Inc.
- Century Therapeutics (IPSC) Slips 8.67% to $1.37, Pressing Toward Key Support - Risk Parity Rebalance
- Century Therapeutics presents CNTY-813 data: what it means for Century Therapeutics stock
- Century Therapeutics to Attend 2026 Jefferies Global Healthcare Conference in London
- Century Therapeutics advances CNTY-813 islet therapy program
- Century Therapeutics presents diabetes therapy data at EASD By Investing.com
- Century Therapeutics (IPSC) Slips 4.97% to $1.53 as Shares Drift Toward Support - Strangle Setup
- Century Therapeutics' CNTY-813 Demonstrates Continued
- Century Therapeutics rated speculative Buy on p...
- Century Therapeutics: Competitors May Be Quietly De-Risking Its Biggest Bet (NASDAQ:IPSC)
- Form 144 Century Therapeutics For: 25 September By Investing.com
Headlines from the last 30 days, linking to the original publishers. See all market news →